Faisal Mahmood

Faisal Mahmood is a Professor at the Department of Clinical Research, University of Southern Denmark (SDU), with dual affiliations at Odense University Hospital (OUH). He is a key member of the Research Unit of Oncology and the AgeCare - Academy of Geriatric Cancer Research in Odense, where he leads advanced research in imaging biomarkers for radiotherapy response. His work bridges clinical oncology and medical physics, with a focus on improving cancer treatment through innovative imaging techniques.

Research Interests: Dr. Mahmood's research centers on imaging biomarkers of response to radiotherapy, with expertise in radiation therapy, medical image processing, and diffusion MRI. His work explores tumor microstructure using time-dependent diffusion imaging and MRI-Linac systems, with applications in glioblastoma and pancreatic cancer. He is actively involved in developing low-dose, adaptive radiotherapy protocols to enhance treatment precision.

The recent trend in his publications shows a strong focus on adaptive radiotherapy, quantitative MRI, and biologically guided treatment. His work integrates engineering principles with clinical oncology, emphasizing reproducibility and feasibility in clinical settings. Topics such as automatic beam gating, diffusion coefficient discrepancies across scanners, and histological validation of imaging biomarkers reflect his translational research approach.

Scientific Awards and Recognition:

• Research supported by Knæk Cancer foundation

Advising and Grants: Dr. Mahmood has supervised at least 3 academic works, including PhD-level research. His projects are supported by institutional and external funding, notably from cancer research foundations. He actively collaborates with multidisciplinary teams across Denmark and internationally, contributing to both national and global oncology research initiatives.

Labs and Research Teams: He is affiliated with the Research Unit of Oncology and the AgeCare - Academy of Geriatric Cancer Research at OUH, where he contributes to cutting-edge research in geriatric oncology and advanced radiotherapy. His team integrates clinical data, imaging physics, and machine learning to develop personalized treatment strategies for cancer patients.